Evaluation of a new endovascular graft for treating aortic aneurysms
Official title: Zenith® Fenestrated+ Endovascular Graft Clinical Study
Run by Cook Group Incorporated · NCT04875429 · Data updated 2026-11-12
This study is testing a new type of graft to see if it can safely and effectively treat aortic aneurysms in patients with specific conditions affecting their major arteries.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 105 (estimated) |
| Sponsor | Cook Group Incorporated Industry-sponsored |
| Locations | 33 sites (Birmingham, Alabama and 32 other locations) |
| Status | Recruiting |
| Started | December 8, 2023 |
| Main results expected | November 2026 |
| Study ends | November 2031 |
| Registry record updated | October 6, 2026 |
| Trial ID | NCT04875429 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with thoracoabdominal, pararenal, or juxtarenal aortic aneurysms measuring 55 mm or more in diameter for males and 50 mm or more for females.
✕Probably not a fit
Patients under 18 years old, those with a life expectancy of less than 2 years, or individuals who are pregnant or breastfeeding will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical study evaluates the safety and effectiveness of the Zenith® Fenestrated+ Endovascular Graft in combination with the BeGraft Balloon-Expandable FEVAR Bridging Stent Graft System and Unibody2 for patients with aortic aneurysms affecting major visceral arteries. The study focuses on patients with thoracoabdominal, pararenal, or juxtarenal aortic aneurysms that meet specific size and growth criteria. Participants will be monitored for outcomes related to the treatment's efficacy and safety.
Why it matters
Potential benefit: If successful, this treatment could provide a less invasive option for managing complex aortic aneurysms, potentially reducing the need for open surgery.
How similar studies have gone: Previous studies involving similar endovascular graft technologies have shown promising results, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Include Criteria: 1. Thoracoabdominal, pararenal or juxtarenal aortic aneurysm with a diameter ≥ 55 mm for males and ≥ 50 mm for females 2. Thoracoabdominal, pararenal or juxtarenal aortic aneurysm with a growth rate of ≥ 5 mm in 6 months 3. Thoracoabdominal, pararenal or juxtarenal aortic aneurysm with aortic diameter \> 2x the normal aortic diameter or saccular aneurysm that warrants treatment in the opinion of the investigator Exclusion Criteria: 1. Age \< 18 years 2. Life expectancy \< 2 years 3. Pregnant, breast-feeding, or planning to become pregnant within 60 months 4. Inability or refusal to give informed consent by the patient or legally authorized representative 5. Unwilling or unable to comply with the follow-up schedule, required clinical assessments, and imaging 6. Simultaneous participation in another investigation study, unless the patient is at least 30 days beyond the primary endpoint of any previous study
Where it's running
-
University of Alabama Birmingham Hospital
Birmingham, Alabama, United States Recruiting -
UC San Diego
La Jolla, California, United States Recruiting -
University of Southern California
Los Angeles, California, United States Recruiting -
Stanford Hospitals and Clinics
Stanford, California, United States Recruiting -
Medstar Washington Hospital Center
Washington D.C., District of Columbia, United States Recruiting -
University of Florida Shands Hospital
Gainesville, Florida, United States Recruiting
Show 27 more locations
-
Tampa General Hospital
Tampa, Florida, United States Recruiting -
Emory University Hospital
Atlanta, Georgia, United States Recruiting -
Northwestern Memorial Hospital
Chicago, Illinois, United States Recruiting -
Endeavor Health Cardiovascular Institute at Glenbrook Hospital
Glenview, Illinois, United States Recruiting -
Loyola University Medical Center
Maywood, Illinois, United States Recruiting -
Edward Hospital
Naperville, Illinois, United States Recruiting -
Methodist Hospital of Indiana
Indianapolis, Indiana, United States Recruiting -
University of Maryland
Baltimore, Maryland, United States Recruiting -
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States Recruiting -
University of Massachusetts
Worcester, Massachusetts, United States Recruiting -
University of Michigan Health System
Ann Arbor, Michigan, United States Recruiting -
Mayo Clinic
Rochester, Minnesota, United States Recruiting -
Barnes Jewish Hospital
St Louis, Missouri, United States Recruiting -
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States Recruiting -
New York University Langone Medical Center
New York, New York, United States Recruiting -
Columbia University Irving Medical Center/NY Presbyterian Hospital
New York, New York, United States Recruiting -
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States Recruiting -
Cleveland Clinic Foundation
Cleveland, Ohio, United States Recruiting -
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States Recruiting -
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States Recruiting -
Medical University of South Carolina
Charleston, South Carolina, United States Recruiting -
Holston Valley Hospital
Kingsport, Tennessee, United States Recruiting -
Ut Southwestern
Dallas, Texas, United States Recruiting -
Memorial Hermann Texas Medical Center/UT Health
Houston, Texas, United States Recruiting -
Massachusetts General Hospital
Boston, Massachusetts, United States Completed -
Carilion Roanoke Memorial Hospital
Roanoke, Virginia, United States Active not recruiting -
St Thomas' Hospital
London, United Kingdom Active not recruiting
Study contacts
- Principal investigator: Gustavo Oderich, MD — Baylor College of Medicine
- Study coordinator: Chanda Bell, RN, BSN
- Email: chanda.bell@cookmedical.com
- Phone: 765-463-7537
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Outcomes after physician-modified fenestrated and branched stent grafts for complex aortic aneurysms
This study will test whether physician-modified fenestrated and branched stent grafts are safe and effective for people with juxtarenal, pararenal, or thoracoabdominal aortic aneurysms who are high risk for open surgery.
-
Remimazolam vs propofol for stable blood pressure during thoracic/abdominal endovascular aortic repair
This trial tests whether remimazolam keeps blood pressure steadier than propofol during TEVAR or EVAR in adults.
-
Using AI to measure aortic size from CT scans
This project will test whether an AI tool called Aorta AIM can automatically measure the aorta on CT scans for adults who have or are being checked for aortic aneurysms.
-
iHub Stent-Graft for Iliac Aneurysms: Safety and Performance in Endovascular Repair
This trial tests the iHub stent-graft to see if it is safe and works well to repair iliac artery aneurysms in adults needing endovascular treatment.
-
Comparing pain relief methods for patients undergoing vascular surgery
This study is testing whether a single shot of a new pain medication can help people having vascular surgery feel less pain compared to the standard pain relief method.
-
Comparing quality of life after different types of aortic aneurysm repair
This study looks at how different types of surgery for abdominal aortic aneurysms affect the quality of life for patients over three years.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.